ELITE PHARMACEUTICALS INC /NV/ 4
4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Aug 19, 2016
Insider Transaction Report
Form 4
Hakim Nasrat A
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2016-08-17+142,857,143→ 142,971,097 total(indirect: see footnote) - Exercise/Conversion
Series I Convertible Preferred Shares
2016-08-17−100→ 0 total(indirect: see footnote)Exercise: $0.00From: 2014-02-07→ Common Stock (142,857,143 underlying)
Holdings
- 21,926,793
Common Stock
- 2,700,000(indirect: By IRA)
Common Stock
Footnotes (3)
- [F1]The preferred shares are convertible into shares of common stock at a rate of 1,428,571.43 shares of common stock for each whole share of preferred stock.
- [F2]The securities are held by Mikah Pharma LLC. Nasrat Hakim is the sole beneficial owner of Mikah Pharma LLC.
- [F3]None